Crossmark

Study protocol for the randomized controlled EVA (early vascular adjustments) trial: tailored treatment of mild hypertension in pregnancy to prevent severe hypertension and preeclampsia

Crossref DOI link: https://doi.org/10.1186/s12884-020-03475-w

Published Online: 2020-12-12

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mulder, Eva http://orcid.org/0000-0003-2689-8528
Ghossein-Doha, Chahinda

Appelman, Evine

van Kuijk, Sander

Smits, Luc

van der Zanden, Rogier

van Drongelen, Joris

Spaanderman, Marc
License Information

Text and Data Mining valid from 2020-12-01

Version of Record valid from 2020-12-12
More Information

Article History

Received: 20 September 2019

Accepted: 3 December 2020

First Online: 12 December 2020

Ethics approval and consent to participate

: The study protocol is reviewed and approved by the ethical committee of the Maastricht University Medical Centre (MEC azM/UM NL52732.068.15 / METC 152017), which covers all study sites. All participants provide written informed consent prior to participation in the trial.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below